BG21417A3 - Метод за получаване на вирусни щамове,които стимулират естествения отбранителен механизъм на организъм-домакин същевременно свободни от антигенно действие - Google Patents

Метод за получаване на вирусни щамове,които стимулират естествения отбранителен механизъм на организъм-домакин същевременно свободни от антигенно действие

Info

Publication number
BG21417A3
BG21417A3 BG022052A BG2205272A BG21417A3 BG 21417 A3 BG21417 A3 BG 21417A3 BG 022052 A BG022052 A BG 022052A BG 2205272 A BG2205272 A BG 2205272A BG 21417 A3 BG21417 A3 BG 21417A3
Authority
BG
Bulgaria
Prior art keywords
stimulate
free
same time
host organism
defense mechanism
Prior art date
Application number
BG022052A
Other languages
Bulgarian (bg)
English (en)
Inventor
Otto Straub
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG21417A3 publication Critical patent/BG21417A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16732—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16764—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BG022052A 1971-12-10 1972-12-06 Метод за получаване на вирусни щамове,които стимулират естествения отбранителен механизъм на организъм-домакин същевременно свободни от антигенно действие BG21417A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2161344A DE2161344C3 (de) 1971-12-10 1971-12-10 Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltend

Publications (1)

Publication Number Publication Date
BG21417A3 true BG21417A3 (bg) 1976-05-20

Family

ID=5827622

Family Applications (1)

Application Number Title Priority Date Filing Date
BG022052A BG21417A3 (bg) 1971-12-10 1972-12-06 Метод за получаване на вирусни щамове,които стимулират естествения отбранителен механизъм на организъм-домакин същевременно свободни от антигенно действие

Country Status (22)

Country Link
JP (2) JPS5924137B2 (enExample)
AR (1) AR204075A1 (enExample)
AT (1) AT326817B (enExample)
AU (1) AU473209B2 (enExample)
BE (1) BE792484A (enExample)
BG (1) BG21417A3 (enExample)
CA (1) CA988848A (enExample)
CH (1) CH577558A5 (enExample)
CS (1) CS189587B2 (enExample)
DD (1) DD108115A5 (enExample)
DE (1) DE2161344C3 (enExample)
DK (1) DK143201C (enExample)
ES (1) ES409464A1 (enExample)
FR (1) FR2162637B1 (enExample)
GB (1) GB1356076A (enExample)
HU (1) HU167086B (enExample)
IE (1) IE36995B1 (enExample)
NL (1) NL178014C (enExample)
PH (1) PH12597A (enExample)
SE (1) SE8400283L (enExample)
SU (1) SU439956A3 (enExample)
ZA (1) ZA728709B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063657A1 (en) * 1981-04-29 1982-11-03 Merck & Co. Inc. Topical application of interferon inducers

Also Published As

Publication number Publication date
ZA728709B (en) 1973-08-29
DK143201C (da) 1981-12-14
NL178014C (nl) 1986-01-02
DD108115A5 (enExample) 1974-09-05
PH12597A (en) 1979-06-27
IE36995B1 (en) 1977-04-13
JPS6011013B2 (ja) 1985-03-22
DK143201B (da) 1981-07-20
FR2162637B1 (enExample) 1976-07-02
DE2161344B2 (de) 1980-05-08
ES409464A1 (es) 1976-03-16
CA988848A (en) 1976-05-11
SE8400283D0 (sv) 1984-01-20
CS189587B2 (en) 1979-04-30
FR2162637A1 (enExample) 1973-07-20
JPS4862919A (enExample) 1973-09-01
DE2161344C3 (de) 1986-10-02
NL178014B (nl) 1985-08-01
IE36995L (en) 1973-06-10
JPS4862912A (enExample) 1973-09-01
GB1356076A (en) 1974-06-12
CH577558A5 (enExample) 1976-07-15
SU439956A3 (ru) 1974-08-15
JPS5924137B2 (ja) 1984-06-07
NL7216628A (enExample) 1973-06-13
AU473209B2 (en) 1976-06-17
SE8400283L (sv) 1984-01-20
AT326817B (de) 1975-12-29
AR204075A1 (es) 1975-11-20
DE2161344A1 (de) 1973-06-20
ATA1041972A (de) 1975-03-15
AU4992072A (en) 1974-06-13
BE792484A (fr) 1973-06-08
HU167086B (enExample) 1975-08-28

Similar Documents

Publication Publication Date Title
NL7404907A (nl) Huid-preparaat.
SE7501655L (sv) Behandling av vevnader.
RO67479A (ro) Procedeu pentru prepararea unor pleuromutiline
SE384529B (sv) Apparat for behandling av djurhudar eller liknande
BE790106A (fr) Dihydropyridazones, leur preparation et leurs utilisations therapeutiques
SU439983A3 (ru) Способ получения производных этиленбензоила
IT949709B (it) Metodo e mezzi per il fraziona mento del sangue
SE435528B (sv) Nicrco-legering, gjutstycke derav och sett att vermebehandla denna
CS191868B2 (en) Method of preparing live virus vaccine
BE791539A (fr) Dihydropyridazones, leur preparation et leurs utilisations therapeutiques
AR192517A1 (es) Miembro oclusor de valvula cardiaca
NL177894C (nl) Hartstimulator.
BG19375A3 (bg) Метод за получаване на 3,4-1н-изохиномин-1-они
BG21417A3 (bg) Метод за получаване на вирусни щамове,които стимулират естествения отбранителен механизъм на организъм-домакин същевременно свободни от антигенно действие
BE790391A (fr) Thiazolinylindoles et thiazinylindoles, leur preparation et leurs utilisations therapeutiques
SE405118B (sv) Sett att framstella 2,4-diamino-5-bensylpyrimidiner
BE781991A (fr) Cyanopyrazines, carbamoyldiaminopyrazines et acides 3-diaminopyrazinoiques et leur preparation
BE783084A (fr) Di-n-oxydes de 2-formyl-3-carboxamido-quinoxalines, leur preparation etleurs utilisations therapeutiques
BE783766A (nl) Verbeterde elektrofotografische werkwijze
ES203614Y (es) Conjunto de bielas y vastagos articulados, perfeccionado.
IT7830643A0 (it) Vaccino anti-tifo e procedimento per la sua preparazione.
BR7204790D0 (pt) Aparelho para estimular batidas cardiacas
AT322091B (de) Impfgeraet
SU460274A1 (ru) Способ получени прозрачной керамики
SU437298A3 (ru) Способ получения производных оксадиазолона